Focus Partners Wealth’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Focus Partners Wealth’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$534K	Sell	4,511 -175	-4%	-$18.9K	﹤0.01%	1929
2026 Q1	$486K	Sell	4,686 -846	-15%	-$89.4K	﹤0.01%	1947
2025 Q4	$578K	Sell	5,532 -375	-6%	-$37.7K	﹤0.01%	1893
2025 Q3	$546K	Hold	5,907	–	–	﹤0.01%	1575
2025 Q2	$472K	Hold	5,907	–	–	﹤0.01%	1470
2025 Q1	$512K	Hold	5,907	–	–	﹤0.01%	1337
2024 Q4	$488K	Buy	+5,907	New	+$508K	﹤0.01%	1339
2024 Q3	–	Sell	-6,032	Closed	-$506K	–	1681
2024 Q2	$506K	Sell	6,032 -55	-0.9%	-$4.37K	﹤0.01%	952
2024 Q1	$478K	Buy	+6,087	New	+$472K	﹤0.01%	731

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

Focus Partners Wealth's PJP Position: Q2 2026 in Review

Focus Partners Wealth reduced its Invesco Pharmaceuticals ETF (PJP) stake by 3.7% in Q2 2026, selling an estimated $18.9K and leaving 4,511 shares worth $534K. The position accounts for ﹤0.01% of the portfolio, ranked #1929.

Focus Partners Wealth first reported a position in PJP in Q1 2024 and has held it in 9 quarters since. The position peaked at $578K in Q4 2025. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

Focus Partners Wealth held 4,511 shares of Invesco Pharmaceuticals ETF worth $534K as of Q2 2026.
Focus Partners Wealth sold 175 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $18.9K.
Invesco Pharmaceuticals ETF made up ﹤0.01% of Focus Partners Wealth's portfolio in Q2 2026, its #1929 holding.
Focus Partners Wealth first reported a position in Invesco Pharmaceuticals ETF in Q1 2024 and has held it in 9 quarters since.
Focus Partners Wealth's Invesco Pharmaceuticals ETF position peaked at $578K in Q4 2025.
117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.